Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer’s disease: randomised, double-blind, placebo-controlled, first-in-human study

查看全文 作　　者：Bengt;Winblad;Niels;Andreasen;Lennart;Minthon;Annette;Floesser;Georges;Imbert;Thomas;Dumortier;R;Paul;Maguire;Kaj;Blennow;Joens;Lundmark;Matthias;Staufenbiel;Jean-Marc;Orgogozo;Ana;Graf 出　　处：《Lancet Neurology》索引2012年第7期,共0页